Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard K Cheng

Showing results (111-120 of 128) with videos related to

Pageof 13
Sort By:
Medrxiv : the Preprint Server for Health Sciences|May 4, 2026
Racial and Ethnic Disparities in Risk of Cardiovascular Disease in Women Treated for Breast CancerSong Yao, Alexa Zimbalist, Haiyang Sheng, et al.
Cardio-Oncology (London, England)|December 18, 2025
Racial differences in breast cancer-specific mortality and CVD-specific mortality after breast cancer in post-menopausal womenKerryn W Reding, Alexi L Vasbinder, Richard K Cheng, et al.
Leukemia & Lymphoma|April 8, 2025
Hematology-oncology provider perspectives regarding lymphoma treatment and cardioprotective strategies in patients with lymphoma at high risk for heart failureEmily Anderson, Yun Choi, Rachel J Buchsbaum, et al.
Journal of the American College of Cardiology|October 27, 2025
Effect of Acoramidis on Recurrent and Cumulative Cardiovascular Outcomes in ATTR-CM: Exploratory Analysis From ATTRibute-CMAhmad Masri, Daniel P Judge, Frederick L Ruberg, et al.
Journal of the National Cancer Institute|November 12, 2020
Cardiovascular Care of the Oncology Patient During COVID-19: An Expert Consensus Document From the ACC Cardio-Oncology and Imaging CouncilsLauren A Baldassarre, Eric H Yang, Richard K Cheng, et al.
Journal of Cardiac Failure|May 13, 2026
Acoramidis, Serum Transthyretin, and Cardiovascular Outcomes in Transthyretin Amyloid Cardiomyopathy: Insights From the ATTRibute-CM TrialAmrut V Ambardekar, Nitasha Sarswat, Richard Wright, et al.
Journal of Cardiac Failure|October 8, 2023
The HFSA Advanced Heart Failure and Transplant Cardiology Fellowship Consensus ConferenceMark H Drazner, Amrut V Ambardekar, Kathryn Berlacher, et al.
ESC Heart Failure|May 15, 2020
Echocardiographic assessment of insulin-like growth factor binding protein-7 and early identification of acute heart failureArzu Kalayci, W Frank Peacock, John T Nagurney, et al.
JACC. Cardiooncology|January 13, 2025
SGLT2i and Primary Prevention of Cancer Therapy-Related Cardiac Dysfunction in Patients With DiabetesAmmar W Bhatti, Rushin Patel, Sourbha S Dani, et al.
JAMA Oncology|November 13, 2025
Immune Checkpoint Inhibitor-Associated Cardiovascular Toxic Effects: International Cardio-Oncology Society Position StatementJoerg Herrmann, Ana Barac, Joseph Carver, et al.
Pageof 13

Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
Medrxiv : the Preprint Server for Health Sciences|May 4, 2026
Racial and Ethnic Disparities in Risk of Cardiovascular Disease in Women Treated for Breast CancerSong Yao, Alexa Zimbalist, Haiyang Sheng, et al.
Cardio-Oncology (London, England)|December 18, 2025
Racial differences in breast cancer-specific mortality and CVD-specific mortality after breast cancer in post-menopausal womenKerryn W Reding, Alexi L Vasbinder, Richard K Cheng, et al.
Leukemia & Lymphoma|April 8, 2025
Hematology-oncology provider perspectives regarding lymphoma treatment and cardioprotective strategies in patients with lymphoma at high risk for heart failureEmily Anderson, Yun Choi, Rachel J Buchsbaum, et al.
Journal of the American College of Cardiology|October 27, 2025
Effect of Acoramidis on Recurrent and Cumulative Cardiovascular Outcomes in ATTR-CM: Exploratory Analysis From ATTRibute-CMAhmad Masri, Daniel P Judge, Frederick L Ruberg, et al.
Journal of the National Cancer Institute|November 12, 2020
Cardiovascular Care of the Oncology Patient During COVID-19: An Expert Consensus Document From the ACC Cardio-Oncology and Imaging CouncilsLauren A Baldassarre, Eric H Yang, Richard K Cheng, et al.
Journal of Cardiac Failure|May 13, 2026
Acoramidis, Serum Transthyretin, and Cardiovascular Outcomes in Transthyretin Amyloid Cardiomyopathy: Insights From the ATTRibute-CM TrialAmrut V Ambardekar, Nitasha Sarswat, Richard Wright, et al.
Journal of Cardiac Failure|October 8, 2023
The HFSA Advanced Heart Failure and Transplant Cardiology Fellowship Consensus ConferenceMark H Drazner, Amrut V Ambardekar, Kathryn Berlacher, et al.
ESC Heart Failure|May 15, 2020
Echocardiographic assessment of insulin-like growth factor binding protein-7 and early identification of acute heart failureArzu Kalayci, W Frank Peacock, John T Nagurney, et al.
JACC. Cardiooncology|January 13, 2025
SGLT2i and Primary Prevention of Cancer Therapy-Related Cardiac Dysfunction in Patients With DiabetesAmmar W Bhatti, Rushin Patel, Sourbha S Dani, et al.
JAMA Oncology|November 13, 2025
Immune Checkpoint Inhibitor-Associated Cardiovascular Toxic Effects: International Cardio-Oncology Society Position StatementJoerg Herrmann, Ana Barac, Joseph Carver, et al.
Pageof 13